José Neto Nailton, Duarte Brito Mário, Gomes Cristiano Dos Santos, Corrêa Luana Caroline de Assunção Cortez, Guerra Gerlane Coelho Bernardo, Guerra Ricardo Oliveira
Graduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Physical Therapy Department, University of Pernambuco, Petrolina, Brazil.
PLoS One. 2025 Jan 2;20(1):e0313193. doi: 10.1371/journal.pone.0313193. eCollection 2025.
Sarcopenia and Osteoporosis are two prevalent conditions in the older population and are defined by low strength, muscle quality/volume and low Bone Mineral Density, respectively. When there is a concomitant presence of both, there is a novel musculoskeletal condition called Osteosarcopenia. These conditions adversely affect quality of life and elevate the risk of fractures, disability, and mortality among older individuals. Dysbiosis of the gut microbiota is the impairment of the mutualistic relationship between microorganisms, metabolic products and the host's immune system. Gut microbiota dysbiosis could be intricately linked to sarcopenia and osteoporosis, shedding light on the complex microbiota-gut-bone-muscle axis. Furthermore, the intestinal microbiota experiences a notable decline in beneficial microorganisms as part of the aging process. The relationship between dysbiosis of the intestinal microbiota in older people and sarcopenia, osteoporosis or osteosarcopenia is still unclear. This review protocol aims to systematically review the literature and compile evidence on the influence of gut microbiota dysbiosis on musculoskeletal function in older people with sarcopenia, osteoporosis or osteosarcopenia.
METHODS/ANALYSIS: This systematic review will analyze observational studies that have investigated the relationship between the effects of gut microbiota dysbiosis and sarcopenia, osteoporosis and osteosarcopenia in older people aged 65 and over. Studies will be retrieved from PubMed/MEDLINE, EMBASE, Scopus, Web of Science and the Cochrane Library. Outcome measures will include body composition for diagnosing osteoporosis and screening for sarcopenia/osteosarcopenia by any criteria. Data synthesis will involve quantitative analysis using summary measures. If sufficient studies, homogeneity and heterogeneity analysis will be performed to conduct Meta-analysis and pooled OR, RR and HR measures will be provided.
肌肉减少症和骨质疏松症是老年人群中两种常见的病症,分别定义为低强度、肌肉质量/体积低和低骨密度。当两者同时存在时,就会出现一种新的肌肉骨骼病症,称为骨肌减少症。这些病症会对生活质量产生不利影响,并增加老年人骨折、残疾和死亡的风险。肠道微生物群失调是指微生物、代谢产物与宿主免疫系统之间互利关系的受损。肠道微生物群失调可能与肌肉减少症和骨质疏松症有着复杂的联系,揭示了复杂的微生物群-肠道-骨骼-肌肉轴。此外,作为衰老过程的一部分,肠道微生物群中有益微生物的数量会显著下降。老年人肠道微生物群失调与肌肉减少症、骨质疏松症或骨肌减少症之间的关系仍不清楚。本综述方案旨在系统地回顾文献,并收集关于肠道微生物群失调对患有肌肉减少症、骨质疏松症或骨肌减少症的老年人肌肉骨骼功能影响的证据。
方法/分析:本系统综述将分析观察性研究,这些研究调查了65岁及以上老年人肠道微生物群失调的影响与肌肉减少症、骨质疏松症和骨肌减少症之间的关系。研究将从PubMed/MEDLINE、EMBASE、Scopus、科学网和考克兰图书馆中检索。结局指标将包括用于诊断骨质疏松症以及通过任何标准筛查肌肉减少症/骨肌减少症的身体成分。数据合成将涉及使用汇总指标的定量分析。如果有足够的研究,将进行同质性和异质性分析以进行荟萃分析,并提供合并的比值比、相对危险度和风险比指标。